St. Jude Children's Research Hospital
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment
- Conditions
- Sarcoma
- Interventions
- Behavioral: InterviewBehavioral: ObservationsBehavioral: Guided Activities
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT02041689
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Vascular Assessment in Adult Survivors of Childhood Cancer
- Conditions
- Cardiovascular RiskPediatric Cancer
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 394
- Registration Number
- NCT02010190
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Transfusional Iron Overload Among Leukemia Survivors
- Conditions
- Acute Lymphocytic LeukemiaAcute Myeloid Leukemia
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2017-05-16
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT01965171
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease
- Conditions
- Sickle Cell Disease
- Interventions
- Other: Questionnaire/Interview
- First Posted Date
- 2013-10-10
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT01959958
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Pain Management in Children and Young Adults With Sickle Cell Disease
- First Posted Date
- 2013-10-07
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT01954927
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
- Conditions
- Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorDesmoplastic Small Round Cell TumorEwing Sarcoma of Bone or Soft TissueMetastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Interventions
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT01946529
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
- Conditions
- Stage II Childhood Hodgkin LymphomaStage IV Childhood Hodgkin LymphomaStage III Childhood Hodgkin Lymphoma
- Interventions
- Drug: Dacarbazine(R)Other: quality of life assessmentRadiation: radiation therapy
- First Posted Date
- 2013-08-12
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 77
- Registration Number
- NCT01920932
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸Maine Children's Cancer Program (MCCP), Scarborough, Maine, United States
🇺🇸Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies
- Conditions
- Non-Hodgkin LymphomaAcute LeukemiaHodgkin Lymphoma
- Interventions
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2017-03-22
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT01900509
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Conditions
- Medulloblastoma
- Interventions
- Radiation: Craniospinal Irradiation with boost to the primary tumor siteOther: Aerobic TrainingOther: Neurocognitive Remediation
- First Posted Date
- 2013-06-17
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 660
- Registration Number
- NCT01878617
- Locations
- 🇺🇸
Rady Children's Hospital, San Diego, California, United States
🇺🇸Texas Children's Cancer Center, Houston, Texas, United States
🇺🇸Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
- Conditions
- Rhabdomyosarcoma
- Interventions
- Procedure: Surgical ResectionProcedure: RadiationDrug: Myeloid Growth FactorProcedure: Lymph Node SamplingDrug: ^1^1C-methionine
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 115
- Registration Number
- NCT01871766
- Locations
- 🇺🇸
Nemours Children's Clinic, Jacksonville, Florida, United States
🇺🇸St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸University of Florida Proton Therapy Institute, Jacksonville, Florida, United States